Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Magnetofluorescent Nanocomposite Comprised of Carboxymethyl Dextran Coated Superparamagnetic Iron Oxide Nanoparticles and β-Diketon Coordinated Europium Complexes.

Han D, Han SY, Lee NS, Shin J, Jeong YG, Park HW, Kim DK.

Nanomaterials (Basel). 2019 Jan 4;9(1). pii: E62. doi: 10.3390/nano9010062.

2.

Magnetofluorescent probe of superparamagnetic iron oxide nanoparticles modified with poly(TMSMA-r-PEGMA-r-Eu(NTA)3(MMA)(TOPO)3).

Kim MC, Kang BS, Sohn Y, Tae KS, Lee HJ, Kim DK, Chang YS.

J Nanosci Nanotechnol. 2014 Nov;14(11):8703-10.

PMID:
25958588
3.

Carboxymethyl dextran-trimethyl chitosan coated superparamagnetic iron oxide nanoparticles: An effective siRNA delivery system for HIV-1 Nef.

Kamalzare S, Noormohammadi Z, Rahimi P, Atyabi F, Irani S, Tekie FSM, Mottaghitalab F.

J Cell Physiol. 2019 May 29. doi: 10.1002/jcp.28655. [Epub ahead of print]

PMID:
31144311
4.

In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting.

Mojica Pisciotti ML, Lima E Jr, Vasquez Mansilla M, Tognoli VE, Troiani HE, Pasa AA, Creczynski-Pasa TB, Silva AH, Gurman P, Colombo L, Goya GF, Lamagna A, Zysler RD.

J Biomed Mater Res B Appl Biomater. 2014 May;102(4):860-8. doi: 10.1002/jbm.b.33068. Epub 2014 Jan 23.

PMID:
24458920
5.

Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs).

Shevtsov M, Nikolaev B, Marchenko Y, Yakovleva L, Skvortsov N, Mazur A, Tolstoy P, Ryzhov V, Multhoff G.

Int J Nanomedicine. 2018 Mar 12;13:1471-1482. doi: 10.2147/IJN.S152461. eCollection 2018.

6.

Evaluation of umbilical cord mesenchymal stem cell labeling with superparamagnetic iron oxide nanoparticles coated with dextran and complexed with Poly-L-lysine.

Sibov TT, Miyaki LA, Mamani JB, Marti LC, Sardinha LR, Pavon LF, Oliveira DM, Cardenas WH, Gamarra LF.

Einstein (Sao Paulo). 2012 Apr-Jun;10(2):180-8. English, Portuguese.

7.

The preliminary study of immune superparamagnetic iron oxide nanoparticles for the detection of lung cancer in magnetic resonance imaging.

Wan X, Song Y, Song N, Li J, Yang L, Li Y, Tan H.

Carbohydr Res. 2016 Jan;419:33-40. doi: 10.1016/j.carres.2015.11.003. Epub 2015 Nov 12.

PMID:
26649917
8.

Development and characterization of magnetic iron oxide nanoparticles with a cisplatin-bearing polymer coating for targeted drug delivery.

Unterweger H, Tietze R, Janko C, Zaloga J, Lyer S, Dürr S, Taccardi N, Goudouri OM, Hoppe A, Eberbeck D, Schubert DW, Boccaccini AR, Alexiou C.

Int J Nanomedicine. 2014 Aug 5;9:3659-76. doi: 10.2147/IJN.S63433. eCollection 2014.

9.

Increased cellular uptake of biocompatible superparamagnetic iron oxide nanoparticles into malignant cells by an external magnetic field.

Prijic S, Scancar J, Romih R, Cemazar M, Bregar VB, Znidarsic A, Sersa G.

J Membr Biol. 2010 Jul;236(1):167-79. doi: 10.1007/s00232-010-9271-4. Epub 2010 Jul 3.

10.

Europium doping of superparamagnetic iron oxide nanoparticles enables their detection by fluorescence microscopy and for quantitative analytics.

Kobayashi Y, Hauptmann R, Kratz H, Ebert M, Wagner S, Taupitz M.

Technol Health Care. 2017;25(3):457-470. doi: 10.3233/THC-161285.

PMID:
27935574
11.

Dextran sulfate-coated superparamagnetic iron oxide nanoparticles as a contrast agent for atherosclerosis imaging.

You DG, Saravanakumar G, Son S, Han HS, Heo R, Kim K, Kwon IC, Lee JY, Park JH.

Carbohydr Polym. 2014 Jan 30;101:1225-33. doi: 10.1016/j.carbpol.2013.10.068. Epub 2013 Oct 26.

PMID:
24299895
12.

The labeling of stem cells by superparamagnetic iron oxide nanoparticles modified with PEG/PVP or PEG/PEI.

Yang G, Ma W, Zhang B, Xie Q.

Mater Sci Eng C Mater Biol Appl. 2016 May;62:384-90. doi: 10.1016/j.msec.2016.01.090. Epub 2016 Feb 4.

PMID:
26952437
13.

Differential effect of polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles on BT-474 human breast cancer cell viability.

Aliakbari M, Mohammadian E, Esmaeili A, Pahlevanneshan Z.

Toxicol In Vitro. 2019 Feb;54:114-122. doi: 10.1016/j.tiv.2018.09.018. Epub 2018 Sep 25.

PMID:
30266435
14.

Protein corona composition of superparamagnetic iron oxide nanoparticles with various physico-chemical properties and coatings.

Sakulkhu U, Mahmoudi M, Maurizi L, Salaklang J, Hofmann H.

Sci Rep. 2014 May 21;4:5020. doi: 10.1038/srep05020.

15.

Magnetic Resonance Imaging of Human-Derived Amniotic Membrane Stem Cells Using PEGylated Superparamagnetic Iron Oxide Nanoparticles.

Naseroleslami M, Parivar K, Khoei S, Aboutaleb N.

Cell J. 2016 Fall;18(3):332-9. Epub 2016 Aug 24.

16.

Polymeric liposomes-coated superparamagnetic iron oxide nanoparticles as contrast agent for targeted magnetic resonance imaging of cancer cells.

Liao Z, Wang H, Lv R, Zhao P, Sun X, Wang S, Su W, Niu R, Chang J.

Langmuir. 2011 Mar 15;27(6):3100-5. doi: 10.1021/la1050157. Epub 2011 Feb 22.

PMID:
21341768
17.

Versatile properties of CaGd₂ZnO₅:Eu³⁺ nanophosphor: its compatibility for lighting and optical display applications.

Raju GS, Pavitra E, Nagaraju G, Yu JS.

Dalton Trans. 2015 Jan 28;44(4):1790-9. doi: 10.1039/c4dt03181d.

PMID:
25474240
18.

Effect of PEG molecular weight on stability, T₂ contrast, cytotoxicity, and cellular uptake of superparamagnetic iron oxide nanoparticles (SPIONs).

Park YC, Smith JB, Pham T, Whitaker RD, Sucato CA, Hamilton JA, Bartolak-Suki E, Wong JY.

Colloids Surf B Biointerfaces. 2014 Jul 1;119:106-14. doi: 10.1016/j.colsurfb.2014.04.027. Epub 2014 May 12.

19.

Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells.

Lindemann A, Lüdtke-Buzug K, Fräderich BM, Gräfe K, Pries R, Wollenberg B.

Int J Nanomedicine. 2014 Oct 29;9:5025-40. doi: 10.2147/IJN.S63873. eCollection 2014.

20.

Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.

Shahnaz G, Kremser C, Reinisch A, Vetter A, Laffleur F, Rahmat D, Iqbal J, Dünnhaupt S, Salvenmoser W, Tessadri R, Griesser U, Bernkop-Schnürch A.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):346-55. doi: 10.1016/j.ejpb.2013.02.010. Epub 2013 Mar 7.

PMID:
23481176

Supplemental Content

Support Center